NorthCrest Asset Manangement’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
119,165
+2,126
| +2% | +$238K | 0.36% | 82 |
|
|
2025
Q1 | $13.1M | Buy |
117,039
+1,366
| +1% | +$153K | 0.4% | 80 |
|
|
2024
Q4 | $10.7M | Buy |
115,673
+98
| +0.1% | +$9.05K | 0.32% | 88 |
|
|
2024
Q3 | $9.69M | Buy |
115,575
+1,252
| +1% | +$105K | 0.29% | 94 |
|
|
2024
Q2 | $7.84M | Buy |
114,323
+1,372
| +1% | +$94.1K | 0.26% | 105 |
|
|
2024
Q1 | $8.27M | Buy |
112,951
+4,068
| +4% | +$298K | 0.28% | 105 |
|
|
2023
Q4 | $8.82M | Sell |
108,883
-665
| -0.6% | -$53.9K | 0.33% | 90 |
|
|
2023
Q3 | $8.21M | Sell |
109,548
-260
| -0.2% | -$19.5K | 0.33% | 95 |
|
|
2023
Q2 | $8.46M | Sell |
109,808
-753
| -0.7% | -$58K | 0.34% | 96 |
|
|
2023
Q1 | $9.17M | Buy |
110,561
+1,351
| +1% | +$112K | 0.38% | 87 |
|
|
2022
Q4 | $9.38M | Sell |
109,210
-2,967
| -3% | -$255K | 0.53% | 65 |
|
|
2022
Q3 | $6.92M | Sell |
112,177
-725
| -0.6% | -$44.7K | 0.37% | 95 |
|
|
2022
Q2 | $6.98M | Buy |
112,902
+1,828
| +2% | +$113K | 0.36% | 100 |
|
|
2022
Q1 | $6.6M | Buy |
111,074
+4,234
| +4% | +$252K | 0.31% | 108 |
|
|
2021
Q4 | $7.76M | Buy |
+106,840
| New | +$7.76M | 0.43% | 78 |
|